Back

Mitochondrial activation drugs

30 August 2016 (16:52 - 17:15)
Organised by:
Congress Presentation Part of: New hope for chronic heart failure therapy Pharmacologic therapy ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Mihai Gheorghiade

Northwestern University, Chicago (United States of America)

3 More presentations in this session

Presentation thumbnail
Contractility enhancement
Professor J. Teerlink (San Francisco, US)
Slides Video
Presentation thumbnail
Beta-3 agonists
Professor J. Balligand (Brussels, BE)
Presentation thumbnail
cGMP activators
Professor B. Pieske (Rostock, DE)
Slides Video

Access the full session

Session thumbnail
New hope for chronic heart failure therapy

The Event

Event poster

ESC Congress 2016

30 August 2016 16:52 CET
You may be interested in
thumbnail
Congress Presentation
Impact of oxygen deficiency on changes in respiratory chain proteins and membrane potential of cardiac mitochondria
29 June 2021
thumbnail
Congress Session
Innovative drug therapies in heart failure
18 May 2025
thumbnail
Congress Presentation
Polydatin, a nutraceutical agent, reduces cardiotoxicity and enhances the anticancer effects of Sunitinib through the reduction of lipid peroxidation and expression of NLRP3 inflammasome
29 June 2021
thumbnail
Congress Presentation
Discovery and in vivo evaluation of novel inhibitors of the hydrolytic activity of mitochondrial F1Fo ATP synthase to alleviate myocardial ischemia reperfusion injury
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources